Anticonvulsant activity of a nonpeptide galanin receptor agonist.
about
Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleusSynthesis of galmic: a nonpeptide galanin receptor agonistGalmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim testsEffects of galanin on cocaine-mediated conditioned place preference and ERK signaling in miceRegulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsyPositive allosteric modulators to peptide GPCRs: a promising class of drugsDeveloping novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy modelsGalnon facilitates extinction of morphine-conditioned place preference but also potentiates the consolidation processPhenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2).Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells.Gene therapy in epilepsy.GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures.Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin.Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex.The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence.Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055Synthesis and biological evaluation of novel pyrimidine derivatives as sub-micromolar affinity ligands of GalR2.Galanin and cognition.Galanin receptors and ligands.Galanin regulates blood glucose level in the zebrafish: a morphological and functional study.Neuropeptides as possible targets in sleep disorders.Galanin protects against behavioral and neurochemical correlates of opiate reward.The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.Alteration of epileptogenesis genes.Emerging treatments for narcolepsy and its related disorders.Expert opinion on pharmacotherapy of narcolepsy.Anticonvulsant neuropeptides as drug leads for neurological diseases.Ghrelin: an emerging new anticonvulsant neuropeptide.Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures.Galanin receptors as a potential target for neurological disease.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.Oleuropein attenuates visceral adiposity in high-fat diet-induced obese mice through the modulation of WNT10b- and galanin-mediated signalings.Galanin and epilepsy: promises with nuances...Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze.
P2860
Q24537325-6323B5A1-6ED9-41B0-B675-71A2FD662648Q24557465-EF8652DE-3E94-49A0-83BC-87788D1B8746Q24559130-C34703B5-FEE6-43A8-87C7-8635C239E728Q24564195-087A8CC6-29A5-4612-8BC8-61A921D8F33FQ24613576-9E972F50-5079-4FAA-A019-B6AD66C286B4Q26859135-9CDBE31A-CC29-4C98-9A4C-48DCEB9C1D62Q27002663-1AED0EE1-B02B-466D-A888-119389B2C830Q28239742-76B74274-1D48-4BD6-96E5-9C01B3E1E40AQ28534362-A1833A42-6630-4208-8D24-8CD584107FD0Q30475920-961810FD-29CA-4C57-8FCE-6BA247AD45DFQ30539653-C9A8BE8E-96F7-4F55-A2D2-BFB0F9D728FDQ33225947-C6F34E93-4031-494A-A311-1B0AE9C2290EQ33960096-B95B6F46-C4B0-4D4C-903E-A4B0A63C4930Q34093567-A8C56F92-A7C6-4C00-8FA6-B6D17C160D53Q34293701-2FE5977E-B67F-4619-BCC9-B768FB716410Q34681134-F61AC946-88C1-46F8-84CC-35C2E667EB79Q34999074-37ED8F9F-46A3-46AC-A3F6-969577CCD082Q35008017-A1023AC0-59DB-49CF-86E5-D46F916DAB68Q35171513-AB34CD15-0355-48C6-8787-E407432C1312Q35222799-54B2E34E-5D64-4937-92E2-E6B78E0D7F88Q35478083-AB6E7867-DDE6-48C1-A47E-574F921E900BQ35753039-BE436134-0581-4CAF-AAC1-0183A50C1056Q36089985-80C48428-B3B5-4BCC-B750-8CCB46F10DE6Q36451712-CDD9D000-A8F6-4052-80E0-AF42C8ACD776Q36456375-2504EA6B-161C-4673-B4C2-50841FB3710DQ36675494-716C09BF-2AA4-4CB0-8F2A-4AED68FF4198Q36824403-386EB51D-0884-4351-BEEC-EF85040DFD84Q36985867-369CC619-3360-4892-ACB9-6DE604E84010Q37426983-DD4293F5-A77C-47C5-8CA5-A5AD1110717BQ37694570-5BFA5EE0-F272-4A8B-818F-ED115E2ED236Q37738902-75C19A22-3C37-4818-A466-FEF2C97907FBQ37845684-C5BD231E-4BDA-427B-8889-7819B761EF20Q37993592-BC4F1A66-7A8C-46B3-95BB-3C179984CCF4Q38316718-8A854D36-B90C-48C3-834E-BA8CED77C9F3Q38556483-43D7A5E3-9FAC-4291-A951-DE4A2BA50ED9Q39006241-A4E04A1E-9B2B-4D23-9BE4-AE890403D2E4Q39830106-2BD4D061-B270-4C6B-841F-E21E7E89E96CQ42798262-ACA340E9-3C20-419F-B655-529CDB8335C5Q42921589-915B72B2-1225-457B-96D5-33F2BB0A8B8EQ44407084-5892084E-00E4-4CE0-9D44-67D041F434DF
P2860
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anticonvulsant activity of a nonpeptide galanin receptor agonist
@nl
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@ast
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en-gb
type
label
Anticonvulsant activity of a nonpeptide galanin receptor agonist
@nl
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@ast
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en-gb
prefLabel
Anticonvulsant activity of a nonpeptide galanin receptor agonist
@nl
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@ast
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en-gb
P2093
P2860
P50
P356
P1476
Anticonvulsant activity of a nonpeptide galanin receptor agonist.
@en
P2093
Andrey M Mazarati
Bo-Ragnar Tolf
Claude Wasterlain
Gerd Hallnemo
Külliki Saar
Sven Hellberg
Tiejun S Shi
Ulo Langel
P2860
P304
P356
10.1073/PNAS.102163499
P407
P50
P577
2002-05-01T00:00:00Z